Literature DB >> 12888581

Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit.

Jorge Cepeda, Samantha Hayman, Tony Whitehouse, Christopher C Kibbler, David Livermore, Mervyn Singer, A Peter R Wilson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888581     DOI: 10.1093/jac/dkg369

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Pharmacokinetics of teicoplanin in an ICU population of children and infants.

Authors:  John C Lukas; Georgios Karikas; Maria Gazouli; Panagiotis Kalabalikis; Tasos Hatzis; Panos Macheras
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

Review 2.  Newer treatment options for skin and soft tissue infections.

Authors:  Murugan Raghavan; Peter K Linden
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.

Authors:  Sameer Dhingra; Nor Azlina A Rahman; Ed Peile; Motiur Rahman; Massimo Sartelli; Mohamed Azmi Hassali; Tariqul Islam; Salequl Islam; Mainul Haque
Journal:  Front Public Health       Date:  2020-11-04

4.  Prospective Study of Irrational Prescription of Teicoplanin in a Large Academic Hospital: A Dilemma of Antimicrobial Resistance.

Authors:  Masoud Hajialigol; Shadi Farsaei; Kiana Shirani
Journal:  J Res Pharm Pract       Date:  2020-03-28

5.  Screening of antibiotic-resistant staphylococci in the nasal cavity of patients and healthy individuals.

Authors:  Naiyf S Alharbi
Journal:  Saudi J Biol Sci       Date:  2019-05-29       Impact factor: 4.219

6.  Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India.

Authors:  Yamuna Devi Bakthavatchalam; Priyanka Babu; Elakkiya Munusamy; Hariharan Triplicane Dwarakanathan; Priscilla Rupali; Marcus Zervos; Peter John Victor; Balaji Veeraraghavan
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.